Latest News

• share
• favorite_border

Should a post-menopausal woman, over the age of 50, who has been diagnosed with cystic ovarian tumors, be alarmed? According to conclusions reached in a new study, "The Malignant Potential of Small Cystic Ovarian Tumors in Women Over 50 Years of Age," published in the April issue of Gynecologic Oncology, alarm is unwarranted, but concern is appropriate.

• share
• favorite_border

Menopausal women who combine estrogen with progestin decrease their risk of developppping endometrial cancer. This is the the conclusion reached by researchers conducting a 22-year retrospective study of women 45 years of age and older.

• share
• favorite_border

Tulane University and University of Rochester medical researchers find that a vaccine therapy for ovarian cancer using genetically altered tumor cells could improve the effectiveness of certain chemotherapy treatments. The research will be presented at the 29th Annual Meeting of the Society of Gynecologic Oncologists.

• share
• favorite_border

Medical researchers from the University of California-Irvine and the State University Hospital at Stony Brook, NY, have determined that a vaginal delivery will result in an increased postpartum regression rate for pregnant women with abnormal antepartum cervical cytology. Their findings will be presented at the 29th Annual Meeting of the Society of Gynecologic Oncologists.

• share
• favorite_border

A revolutionary new tool has been introduced which will help women determine their risk of being attacked by one of the most deadly of all killers: reproductive cancer (cancer of the ovaries, uterus, and cervix). The Women's Cancer Network (WCN) website, at www.wcn.org, is the world's first interactive reproductive cancer website and allows a woman to instantly receive an assessment of her risk for developing these cancers.

• share
• favorite_border

Approximately 80% of women with cervical cancer receive a favorable prognosis if treated with a radical hysterectomy and early radiotherapy. However, in the last 30 years, the 20% mortality rate of patients following surgery has not improved. Now, medical researchers specializing in the treatment of women's cancers have completed research that offers hope to women recovering from treatment for this deadly disease. Their findings will be presented at the 29th Annual Meeting of the Society of Gynecologic Oncologists.

• share
• favorite_border

Medical researchers from the University of Pennsylvania Cancer Center and the Memorial Sloan-Kettering Cancer Center have conducted the first long-term follow-up of ovarian cancer patients having a negative second-look laparotomy, after treatment with platinum-based chemotherapy. Their findings will be presented at the 29th Annual Meeting of the Society of Gynecologic Oncologists.

• share
• favorite_border

Findings regarding vaccine therapy for ovarian cancer, platinum-based chemotherapy, the effect of route of delivery in the post-partum period and pelvic radiation therapy for cervical cancer take center stage at the 29th Annual Meeting of the Society of Gynecologic Oncologists.

• share
• favorite_border

Newly Released Study Recommends Genetic Testing of Gynecologic Cancer Victims in this High Risk Group, Regardless of Family History

• share
• favorite_border

The Society of Gynecologic Oncologists (SGO) is a non-profit, international organization of obstetricians-gynecologists who specialize in treating women with cancers of the ovary, uterus, cervix, vagina, vulva and fallopian tubes. These women's healthcare specialists have extensive training in providing gynecologic cancer care to women, including surgery, chemotherapy, immunotherapy and other innovative approaches that enhance patient care.

• share
• favorite_border

Gynecologic Oncology, Journal for the Society of Gynecologic Oncologists, Reports Findings That Additional Test Has Limited Clinical Benefits